Skip to content

Clinical trials

Completed Central Nervous System Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Status: Completed Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20101
20113
20171
20182
20201
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Capital Medical University2
Changhai Hospital1
Eisai Limited1
Hangzhou Normal University1
Neuroscience Trials Australia1
Sinotau Pharmaceutical Group1
Southern Medical University, China1
Takeda1
The George Institute for Global Health, China1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases14
Brain Diseases7
Nervous System Diseases6
Stroke5
Cardiovascular Diseases4
Cerebral Infarction3
Cerebrovascular Disorders3
Dementia3
Vascular Diseases3
Alzheimer Disease2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.